Published in Hum Reprod on February 01, 1998
Pathogenesis of Afa/Dr diffusely adhering Escherichia coli. Clin Microbiol Rev (2005) 1.51
Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. Infect Immun (2004) 0.85
Nitric oxide synthases and tubal ectopic pregnancies induced by Chlamydia infection: basic and clinical insights. Mol Hum Reprod (2010) 0.82
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol (1999) 5.02
Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest (2001) 4.37
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med (2001) 3.96
Headache in the emergency department. Headache (2001) 2.87
Worst headache and subarachnoid hemorrhage: prospective, modern computed tomography and spinal fluid analysis. Ann Emerg Med (1998) 2.10
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother (1996) 1.83
A new twist in trypanosome RNA metabolism: cis-splicing of pre-mRNA. RNA (2000) 1.79
Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest (1999) 1.62
[Placebo-controlled study of melbrosia in treatment of climacteric symptoms]. Wien Med Wochenschr (1994) 1.42
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene (1989) 1.41
Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on. Lancet (1990) 1.41
[Tumoral vascular density in breast tumors and their effect on recurrence-free survival]. Chirurg (1994) 1.40
MMP-1 and MMP-2 expression in uterine leiomyosarcoma and correlation with different clinicopathologic parameters. J Soc Gynecol Investig (2003) 1.40
[Adjuvant hormonal therapy in lymph node-negative breast carcinoma patients in the postmenopause]. Dtsch Med Wochenschr (1992) 1.39
Fourteen-year experience with laparoscopic ventrosuspension in patients with retroverted and retroflected uterus and pelvic pain syndromes. J Minim Invasive Gynecol (2010) 1.39
The mythology of hormone replacement therapy. Br J Obstet Gynaecol (1997) 1.37
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol (1999) 1.34
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol (2001) 1.33
Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet (2000) 1.30
Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol (1996) 1.30
Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer (1994) 1.27
Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes. J Biol Chem (2001) 1.27
EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res (1997) 1.26
Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. Int J Cancer (1997) 1.16
Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat (1999) 1.15
Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol (1998) 1.15
Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors. Breast Cancer Res Treat (2003) 1.12
Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum Reprod (2003) 1.11
Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol (1995) 1.09
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology (2004) 1.07
The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod (2004) 1.06
Propolis solution for the treatment of chronic vaginitis. Int J Gynaecol Obstet (2005) 1.06
Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol (1995) 1.05
Hormone replacement therapy and intraocular pressure. Maturitas (1997) 1.04
CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol (1996) 1.03
Estrogen-metabolizing gene polymorphisms and age at natural menopause in Caucasian women. Hum Reprod (2005) 1.02
Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod (1999) 0.99
Human papillomavirus in the cervix and placenta. Obstet Gynecol (2000) 0.99
Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum Reprod (2001) 0.99
Expression of the CD40 antigen on normal endothelial cells and in benign and malignant tumours of vascular origin. Histopathology (1996) 0.98
The association of variants in the FTO gene with longitudinal body mass index profiles in non-Hispanic white children and adolescents. Int J Obes (Lond) (2011) 0.98
Human keratinocytes express cellular prion-related protein in vitro and during inflammatory skin diseases. Am J Pathol (1998) 0.98
Primary malignant melanoma of the vagina: long-term remission following radiation therapy. Gynecol Oncol (1998) 0.95
Reduction of intraocular pressure in a glaucoma patient undergoing hormone replacement therapy. Maturitas (1998) 0.95
Reverse transcription-polymerase chain reaction products of alternatively spliced mRNAs form DNA heteroduplexes and heteroduplex complexes. J Biol Chem (1999) 0.94
Irradiated cultured apoptotic peripheral blood mononuclear cells regenerate infarcted myocardium. Eur J Clin Invest (2009) 0.94
Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy (2012) 0.94
Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil Steril (2001) 0.94
Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol (1999) 0.93
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer (1993) 0.93
The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. J Soc Gynecol Investig (2001) 0.92
Quantitative determination of gene expression by competitive reverse transcription-polymerase chain reaction in degraded RNA samples. Anal Biochem (1997) 0.92
Premature ovarian failure: etiology and prospects. Gynecol Endocrinol (2000) 0.91
Oral administration of methylglyoxal leads to kidney collagen accumulation in the mouse. Life Sci (1998) 0.90
Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother (1988) 0.90
Radioimmunodetection in patients with suspected ovarian cancer. J Nucl Med (1985) 0.90
A polymorphism of the interleukin-6 gene promoter and idiopathic recurrent miscarriage. Hum Reprod (2003) 0.90
Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. Int J Gynecol Cancer (2007) 0.89
Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci (2007) 0.89
Differential expression of cell surface integrins on human mast cells and human basophils. Ann Hematol (1992) 0.89
Characterization of a cDNA clone, encoding a 70 kDa heat shock protein from the dermatophyte pathogen Trichophyton rubrum. Gene (2000) 0.89
Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. Br J Cancer (2003) 0.89
Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer (2007) 0.89
Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int J Cancer (1994) 0.88
Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet (2007) 0.88
The influence of hormone replacement therapy on skin ageing: a pilot study. Maturitas (2001) 0.88
Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas (2002) 0.88
HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples. Eur J Cancer (1993) 0.88
Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer (1995) 0.88
A prospective, randomized, double-blind, placebo-controlled study on the influence of a hormone replacement therapy on skin aging in postmenopausal women. Climacteric (2007) 0.87
Axillary lymph nodes in breast cancer: is size related to metastatic involvement? World J Surg (2000) 0.87
Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat (1999) 0.87
Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Lett (1998) 0.87
Interleukin 1alpha and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis. Hum Reprod (2005) 0.87
Microdissection as a means to verify allelic imbalance in tumour biology samples. Anticancer Res (1996) 0.87
The creation of evidence in 'evidence-based' drug prevention: a critique of the Strengthening Families Program Plus Life Skills Training evaluation. Drug Alcohol Rev (2007) 0.86
A predictive model for endometriosis. Hum Reprod (2005) 0.86
The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest (1999) 0.86
Human melanocytes and melanoma cells constitutively express the Bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol (1995) 0.86
Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell lines. Breast Cancer Res Treat (1996) 0.85
Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Clin Cancer Res (1999) 0.85